Biomaxima (WAR:BMX) Valuation Rank

View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Biomaxima Valuation Rank Related Terms

Thank you for viewing the detailed overview of Biomaxima's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomaxima Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Vetterow Street, Lublin, POL, 20-277

Website

https://www.biomaxima.com

BioMaxima SA is a Polish company operating in the market of laboratory diagnostics. It is a manufacturer of microbiological substrates as well as a wide range of reagents and diagnostic equipment. The company is also a distributor of products of recognized multinational diagnostic companies such as: Accelerate Diagnostics, Nova Biomedical, PHC Group, Technoclone, Kabe and Biolog.